“Joining PetVivo as a new Field Veterinary Business Development Manager is an incredible opportunity for me to continue my ...

Low-volatility stocks are attractive now because they provide stability and reduce risk during market downturns, delivering ...

According to the Merck Veterinary Manual ... Written and researched by the Insider Reviews team. We highlight products and services you might find interesting. If you buy them, we may get a ...

Merck & Co., Inc. is a global health care company ... Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products and health ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...